2-{[2-({[(4-chloroanilino)carbonyl]oxy}imino)-3,3-dimethylbutyl]thio}pyridinium-1-olate

Catalog No. :
ACOCLP671
CAS No. :
647825-27-2
Molecular Formula :
C18H20ClN3O3S
Molecular Weight :
393.90

IUPAC Name:(E)-2-((2-((((4-chlorophenyl)carbamoyl)oxy)imino)-3,3-dimethylbutyl)thio)pyridine 1-oxide

2-{[2-({[(4-chloroanilino)carbonyl]oxy}imino)-3,3-dimethylbutyl]thio}pyridinium-1-olate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-{[2-({[(4-chloroanilino)carbonyl]oxy}imino)-3,3-dimethylbutyl]thio}pyridinium-1-olate
IUPAC Name(E)-2-((2-((((4-chlorophenyl)carbamoyl)oxy)imino)-3,3-dimethylbutyl)thio)pyridine 1-oxide
MDL No.MFCD03659709
Molecular FormulaC18H20ClN3O3S
Molecular Weight393.90
SMILES[O-][N+]1=CC=CC=C1SC/C(C(C)(C)C)=N/OC(NC2=CC=C(Cl)C=C2)=O
InChI KeyJOYRDPUSZRLNEQ-QNGOZBTKSA-N
Synonym2-Butanone, 3,3-dimethyl-1-[(1-oxido-2-pyridinyl)thio]-, O-[[(4-chlorophenyl)amino]carbonyl]oxime (9CI)
CAS No.647825-27-2

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACOCLP671 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACOCLP671 route product structure diagram
    ACOCLP671647825-27-2
Inquiry

2. ACOCLP671 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACEBHP642 route compound structure diagram
    ACEBHP6421121-31-9 In Stock
  4. Then
  5. ACOCLP671 route product structure diagram
    ACOCLP671647825-27-2
Inquiry

Comments (0)